RITTER PHARMACEUTICALS INC's ticker is RTTR and the CUSIP is 767836109. A total of 13 filers reported holding RITTER PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,000 | – | 4,925 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Financial Advisors, LLC | 10,000 | $6,000 | 0.00% |
| Baker Brothers Advisors | 400,000 | $220,000 | 0.00% |
| Alyeska Investment Group, L.P. | 293,109 | $161,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,000 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 29,614 | $16,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 10,680 | $6,000 | 0.00% |
| DEUTSCHE BANK AG\ | 6,614 | $3,000 | 0.00% |
| BlackRock Inc. | 70,219 | $39,000 | 0.00% |
| Bank of New York Mellon Corp | 13,304 | $7,000 | 0.00% |
| Citadel Advisors | 10,003 | $6,000 | 0.00% |